Metricap aims to become the first company in the world to provide a metered dose dispensing closure for squeezable tubes, for which there are numerous application opportunities in the pharmaceutical industry as well as for the mixing of exact amounts of epoxy for adhesives and the mixing of chemical pastes in industry and large scale packaging lines.


Key Oncologics is a newly developed South African biopharmaceutical company fully dedicated to the treatment of cancer and allied diseases in the South African market place. Key Oncologics has a sound knowledge in the management and treatment of cancer. Key Oncologics has a clinical trial division with the necessary infrastructure to conduct Oncology Clinical Trials according to GCP.


ComGenex is in the business of synthesizing and supplying novel research grade 'drug like' organic substances for Classical & High Throughput Screening. Many have valued the relevance and high quality of our products, and with the vast experience gained from many successful collaborations we have developed a suite of relevant and facilitative services to ensure that ComGenex will be able to support and meet your present and future drug discovery requirements.


deCODE is a biopharmaceutical company applying its discoveries in human genetics to develop drugs and diagnostics for common diseases. deCODE is a global leader in gene discovery - our population approach and resources have enabled us to isolate key genes contributing to major public health challenges from cardiovascular disease to cancer, genes that are providing us with drug targets rooted in the basic biology of disease.


Exigon is a biotech company that focuses on development of enabling technology platforms and novel DNA- and immuno-diagnostic products against common genetic diseases, in particular, cardio-vascular, diabetic and other chronic and degenerative diseases. Exigon is focused on the development of enabling technology platforms and novel DNA- and immuno-diagnostic products against common genetic diseases, in particular, cardio-vascular, diabetic and other chronic and degenerative diseases.


AdvanDx is a molecular diagnostic company committed to provide the medical profession with advanced in vitro diagnostic kits, such as PNA FISH for rapid and simple pathogen identification in blood cultures and screening test for the prevention of hospital acquired infections, leading to improved therapy and better patient management.


Biolipox is a research-intensive pharmaceutical company. The company is developing novel drugs to treat respiratory and inflammatory diseases, including asthma, Chronic Obstructive Pulmonary Disease (COPD), rhinitis, arthritis pain, and general pain. OxTher is a clinical stage biotechnology company. The company develops products, based on its cell- and enzyme based proprietary technologies, for metabolic disorders based on excess oxalate from endogenous and exogenous sources.


OxTher will market and sell its orphan drug products to treat and prevent hyperoxaluria and kidney stones in indications such as Primary and Enteric Hyperoxaluria.